Clinical trial
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With…
NCT00312221 · Purdue Pharma LP, Industry · Terminated
Key facts
| NCT number | NCT00312221 |
|---|---|
| Title | Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis Pain |
| Official title | Randomized, Double-blind, Multicenter Study to Determine the Efficacy and Safety of BTDS 20 or Oxycodone Immediate-Release (OxyIR) Versus BTDS 5 in Subjects With Moderate to Severe Osteoarthritis (OA) Pain |
| Lead sponsor | Purdue Pharma LP, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | Buprenorphine, oxycodone immediate-release |
| Enrollment | 418 |
| Start date | Apr 1, 2004 |
| Primary completion | Jul 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Apr 7, 2006 |
| Last update posted | Sep 10, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: